Add Yahoo as a preferred source to see more of our stories on Google. The Senate Committee on Energy and Natural Resources convened March 19 for a full committee hearing to examine the Department of ...

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 Earnings Call Transcript March 17, 2026 Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09657.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

A year ago, the internal civil rights and detention watchdogs were gutted. Now, accountability is out of reach while abuses ...